241 related articles for article (PubMed ID: 26679830)
21. Are there missed opportunities for vaccinating against hepatitis B among people who inject drugs in the UK?
Njoroge J; Hope VD; O'Halloran C; Edmundson C; Glass R; Parry JV; Ncube F
Epidemiol Infect; 2019 Jan; 147():e244. PubMed ID: 31364574
[TBL] [Abstract][Full Text] [Related]
22. The outcome of a rapid hepatitis B vaccination programme in a methadone treatment clinic.
Ramasamy P; Lintzeris N; Sutton Y; Taylor H; Day CA; Haber PS
Addiction; 2010 Feb; 105(2):329-34. PubMed ID: 20078489
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities.
Bowman S; Grau LE; Singer M; Scott G; Heimer R
BMC Public Health; 2014 Aug; 14():820. PubMed ID: 25107530
[TBL] [Abstract][Full Text] [Related]
24. Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
Rey D; Piroth L; Wendling MJ; Miailhes P; Michel ML; Dufour C; Haour G; Sogni P; Rohel A; Ajana F; Billaud E; Molina JM; Launay O; Carrat F;
Lancet Infect Dis; 2015 Nov; 15(11):1283-91. PubMed ID: 26257021
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B vaccination uptake in hard-to-reach populations in London: a cross-sectional study.
Taylor JEB; Surey J; MacLellan J; Francis M; Abubakar I; Stagg HR
BMC Infect Dis; 2019 May; 19(1):372. PubMed ID: 31046683
[TBL] [Abstract][Full Text] [Related]
26. The Effect of Oral Levamisole Co-administration on the Level of Immune Response to Hepatitis B Vaccine in Healthy Individuals: A Randomized Clinical Trial.
Hosseini M; Shalchiantabrizi P; Dadgarmoghaddam M; Ahmady-Simab S; Behjati A; Salari M
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):219-227. PubMed ID: 28732435
[TBL] [Abstract][Full Text] [Related]
27. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
[TBL] [Abstract][Full Text] [Related]
28. Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre.
Macdonald V; Dore GJ; Amin J; van Beek I
Sex Health; 2007 Mar; 4(1):27-30. PubMed ID: 17382034
[TBL] [Abstract][Full Text] [Related]
29. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
Avdicova M; Crasta PD; Hardt K; Kovac M
Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
[TBL] [Abstract][Full Text] [Related]
30. Surface antibody and cytokine response to recombinant Chinese hamster ovary cell (CHO) hepatitis B vaccine.
Zhang W; Han L; Lin C; Wang H; Pang X; Li L; Gao P; Lin H; Gong X; Tang Y; Ma J; Zhang H; Wang C; Yang P; Li H; Sun M; He X
Vaccine; 2011 Aug; 29(37):6276-82. PubMed ID: 21722684
[TBL] [Abstract][Full Text] [Related]
31. Predictors of hepatitis B vaccination completion among people who use drugs participating in a national program of targeted vaccination.
Raven S; Urbanus A; de Gee A; Hoebe C; van Steenbergen J
Vaccine; 2018 Aug; 36(35):5282-5287. PubMed ID: 30061025
[TBL] [Abstract][Full Text] [Related]
32. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
[TBL] [Abstract][Full Text] [Related]
33. Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial.
Hwang LY; Grimes CZ; Tran TQ; Clark A; Xia R; Lai D; Troisi C; Williams M
J Infect Dis; 2010 Nov; 202(10):1500-9. PubMed ID: 20936979
[TBL] [Abstract][Full Text] [Related]
34. [Status of vaccination against hepatitis B among postgraduate students in medical higher education institutions in Guangzhou].
Lin CS; Zhu JY; Mai L; Lee WH; Gao ZL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):114-6. PubMed ID: 17653308
[TBL] [Abstract][Full Text] [Related]
35. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
[TBL] [Abstract][Full Text] [Related]
36. Sci-B-VacTM Vs ENGERIX-B Vaccines for Hepatitis B Virus in Patients with Inflammatory Bowel Diseases: A Randomised Controlled Trial.
Etzion O; Novack V; Perl Y; Abel O; Schwartz D; Munteanu D; Abufreha N; Ben-Yaakov G; Maoz ED; Moshaklo A; Dizingf V; Fich A
J Crohns Colitis; 2016 Aug; 10(8):905-12. PubMed ID: 26928962
[TBL] [Abstract][Full Text] [Related]
37. The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C.
Idilman R; De MN; Colantoni A; Nadir A; Van Thiel DH
Am J Gastroenterol; 2002 Feb; 97(2):435-9. PubMed ID: 11866284
[TBL] [Abstract][Full Text] [Related]
38. WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs.
Walsh N; Verster A; Rodolph M; Akl EA
Int J Drug Policy; 2014 May; 25(3):363-71. PubMed ID: 24561223
[TBL] [Abstract][Full Text] [Related]
39. Anti-hepatitis B core antibody is not required for prevaccination screening in healthcare workers.
Shim J; Kim KY; Kim BH; Chun H; Lee MS; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
Vaccine; 2011 Feb; 29(8):1721-6. PubMed ID: 21147128
[TBL] [Abstract][Full Text] [Related]
40. CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
Fuster F; Vargas JI; Jensen D; Sarmiento V; Acuña P; Peirano F; Fuster F; Arab JP; Martínez F;
Vaccine; 2016 Apr; 34(16):1889-95. PubMed ID: 26945101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
